The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price N/A of N/A this year. Over the last six months, there has been a stronger performance of -5.30%. The price of IBO fallen by 224.26% during the last 30 days period. For the last 5-days stocks have improved 285.26%.
Impact BioMedical Inc’s stock has had a calm market performance.
52-week price history of IBO Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Impact BioMedical Inc’s current trading price is -70.99% away from its 52-week high, while its distance from the 52-week low is 394.31%. The stock’s price range for this period has been between $0.36 and $6.17. The Healthcare sector company’s shares saw a trading volume of about 274.87 million for the day, which was higher than the average daily volume of 9.24 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Impact BioMedical Inc (IBO) has experienced a quarterly rise of 237.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 21.64M and boasts a workforce of 2 employees.
How Moving Averages and Trading Volume Data Work Together
IBO’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for IBO stands at 2.38. Similarly, the long-term debt-to-equity ratio is also 0.00.
